1. Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial. (14th May 2019) Authors: Qiao, You-Lin; Wu, Ting; Li, Rong-Cheng; Hu, Yue-Mei; Wei, Li-Hui; Li, Chang-Gui; Chen, Wen; Huang, Shou-Jie; Zhao, Fang-Hui; Li, Ming-Qiang; Pan, Qin-Jing; Zhang, Xun; Li, Qing; Hong, Ying; Zhao, Chao; Zhang, Wen-Hua; Li, Yan-Ping; Chu, Kai; Li, Mei; Jiang, Yun-Fei Journal: Journal of the National Cancer Institute Issue: Volume 112:Number 2(2020) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial. Issue 12 (December 2022) Authors: Zhao, Fang-Hui; Wu, Ting; Hu, Yue-Mei; Wei, Li-Hui; Li, Ming-Qiang; Huang, Wei-Jin; Chen, Wen; Huang, Shou-Jie; Pan, Qin-Jing; Zhang, Xun; Hong, Ying; Zhao, Chao; Li, Qing; Chu, Kai; Jiang, Yun-Fei; Li, Ming-Zhu; Tang, Jie; Li, Cai-Hong; Guo, Dong-Ping; Ke, Li-Dong Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial. Issue 32 (31st July 2015) Authors: Wu, Ting; Hu, Yue-Mei; Li, Juan; Chu, Kai; Huang, Shou-Jie; Zhao, Hui; Wang, Zhong-Ze; Yang, Chang-Lin; Jiang, Han-Min; Wang, Yi-Jun; Lin, Zhi-Jie; Pan, Hui-Rong; Sheng, Wei; Wei, Fei-Xue; Li, Shao-Wei; Wang, Ying; Zhu, Feng-Cai; Li, Chang-Gui; Zhang, Jun; Xia, Ning-Shao Journal: Vaccine Issue: Volume 33:Issue 32(2015) Page Start: 3940 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals. Issue 7 (2nd July 2020) Authors: Yu, Xiao-Juan; Li, Juan; Lin, Zhi-Jie; Zhao, Hui; Lin, Bi-Zhen; Qiao, You-Lin; Hu, Yue-Mei; Wei, Li-Hui; Li, Rong-Cheng; Huang, Wei-Dan; Wu, Ting; Huang, Shou-Jie; Li, Chang-Gui; Pan, Hui-Rong; Zhang, Jun Journal: Human vaccines & immunotherapeutics Issue: Volume 16:Issue 7(2020) Page Start: 1630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals. Issue 7 (2nd July 2020) Authors: Yu, Xiao-Juan; Li, Juan; Lin, Zhi-Jie; Zhao, Hui; Lin, Bi-Zhen; Qiao, You-Lin; Hu, Yue-Mei; Wei, Li-Hui; Li, Rong-Cheng; Huang, Wei-Dan; Wu, Ting; Huang, Shou-Jie; Li, Chang-Gui; Pan, Hui-Rong; Zhang, Jun Journal: Human vaccines & immunotherapeutics Issue: Volume 16:Issue 7(2020) Page Start: 1630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response. Issue 1 (1st January 2021) Authors: Zhuang, Chun-Lan; Lin, Zhi-Jie; Bi, Zhao-Feng; Qiu, Ling-Xian; Hu, Fang-Fang; Liu, Xiao-Hui; Lin, Bi-Zhen; Su, Ying-Ying; Pan, Hui-Rong; Zhang, Tian-Ying; Huang, Shou-Jie; Hu, Yue-Mei; Qiao, You-Lin; Zhu, Feng-Cai; Wu, Ting; Zhang, Jun; Xia, Ning-Shao Journal: Emerging microbes & infections Issue: Volume 10:Issue 1(2021) Page Start: 365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial. Issue 7 (2nd July 2020) Authors: Su, Ying-Ying; Lin, Bi-Zhen; Zhao, Hui; Li, Juan; Lin, Zhi-Jie; Qiao, You-Lin; Wei, Li-Hui; Hu, Yue-Mei; Li, Rong-Cheng; Zhuang, Si-Jie; Sun, Guang; Zheng, Zi-Zheng; Huang, Shou-Jie; Wu, Ting; Zhang, Jun; Pan, Hui-Rong; Li, Chang-Gui Journal: Human vaccines & immunotherapeutics Issue: Volume 16:Issue 7(2020) Page Start: 1636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial. Issue 7 (2nd July 2020) Authors: Su, Ying-Ying; Lin, Bi-Zhen; Zhao, Hui; Li, Juan; Lin, Zhi-Jie; Qiao, You-Lin; Wei, Li-Hui; Hu, Yue-Mei; Li, Rong-Cheng; Zhuang, Si-Jie; Sun, Guang; Zheng, Zi-Zheng; Huang, Shou-Jie; Wu, Ting; Zhang, Jun; Pan, Hui-Rong; Li, Chang-Gui Journal: Human vaccines & immunotherapeutics Issue: Volume 16:Issue 7(2020) Page Start: 1636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial. Issue 6 (30th November 2022) Authors: Mo, Zhao-Jun; Bi, Zhao-Feng; Sheng, Wei; Chen, Qi; Huang, Teng; Li, Ming-Qiang; Cui, Xue-Lian; Wangjiang, Ya-Hui; Lin, Bi-Zhen; Zheng, Feng-Zhu; Sun, Guang; Li, Ya-Fei; Zheng, Ya; Zhuang, Si-Jie; Su, Ying-Ying; Pan, Hui-Rong; Huang, Shou-Jie; Wu, Ting; Zhang, Jun; Xia, Ning-Shao Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗